The FDA plans to grant full approval of the Pfizer vaccine on Monday: report

The Food and Drug Administration is preparing to grant full approval of Pfizer-BioNTech’s COVID-19 vaccine on Monday, according to a report Friday.

The New York Times reported that approval was initially intended for Labor Day, but was streamlined due to the recent rise in the more infectious Delta variant of the virus.

The December 11, 2020, two-dose vaccine was the first COVID-19 feature to receive emergency use authorization and would be the first to be fully approved by the federal agency.

The FDA had wanted to end approval on Friday, the Times reported, but regulators and the company continue to negotiate.

Full approval of the Modern vaccine could be in a few weeks, as the FDA continues to review its application, according to the report.

The Modern Two-Dose Vaccine received emergency approval on December 18, 2020, followed by the firing of Johnson & Johnson on February 27.

On Friday, the FDA did not immediately return any requests for comments from The Post.

Last week, the Immunization Practice Advisory Committee (ACIP) of the Centers for Disease Control and Prevention (ACIP) unanimously approved that the agency recommend “an additional dose” of Pfizer or Moderna vaccines for those with compromised immune systems.

Full approval of the Modern vaccine could be in a few weeks, as the FDA continues to review its application, according to the report.
Full approval of the Modern vaccine could be in a few weeks, as the FDA continues to review its application, according to the report.
AP

President Biden on Wednesday unveiled a plan for vaccinated people to receive a booster shot eight months after their initial coup, pending FDA approval.

The CDC wants to roll out the booster program the week of Sept. 20, director Rochelle Walensky said this week, citing new data showing a decline in vaccine effectiveness over time against mild infections and moderate.

“We are concerned that current strong protection against serious infections, hospitalization and death may decline in the coming months, especially among those at higher risk or who have been vaccinated before,” Walensky warned in a briefing. COVID of the White House. “In the context of these concerns, we are planning for Americans to receive reinforcements.”

Mayor Bill de Blasio announced earlier this week that he expects booster doses to be available to New Yorkers next month.

“There will be more and more opportunities for people to get drivers and we will not just encourage it,” de Blasio said. “We’ll make it easy and free, as always.”

.Source